Showing 2,121 - 2,140 results of 5,273 for search 'significantly ((((((mean decrease) OR (nn decrease))) OR (greater decrease))) OR (linear decrease))', query time: 0.42s Refine Results
  1. 2121

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  2. 2122
  3. 2123
  4. 2124
  5. 2125
  6. 2126

    a, Anti-correlation of gene expression between <i>dmdR1</i> and its predicted regulon. Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875.... by Hannah E. Augustijn (10773096)

    Published 2025
    “…Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875. …”
  7. 2127

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  8. 2128

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  9. 2129
  10. 2130
  11. 2131
  12. 2132

    Flow diagram of participants selection. by Wei Huang (36889)

    Published 2025
    “…Multivariable logistic regression evaluated associations between BRI and LMM, while multivariable linear regression assessed relationships between BRI and appendicular skeletal muscle mass (ASM)/BMI. …”
  13. 2133

    Minimal data set. by Wei Huang (36889)

    Published 2025
    “…Multivariable logistic regression evaluated associations between BRI and LMM, while multivariable linear regression assessed relationships between BRI and appendicular skeletal muscle mass (ASM)/BMI. …”
  14. 2134

    Weighted comparison of baseline characteristics. by Wei Huang (36889)

    Published 2025
    “…Multivariable logistic regression evaluated associations between BRI and LMM, while multivariable linear regression assessed relationships between BRI and appendicular skeletal muscle mass (ASM)/BMI. …”
  15. 2135
  16. 2136
  17. 2137
  18. 2138
  19. 2139
  20. 2140